SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2011 / Cilt: 39 - Sayı: 4

The impact of chronic kidney disease on in-hospital clinical outcomes in patients undergoing primary percutaneous angioplasty for ST-segment elevation myocardial infarction

Primer anjiyoplasti uygulanan ST yükselmeli miyokart enfarktüslü hastalarda kronik böbrek hastalığının hastaneiçi klinik sonuçlar üzerine etkisi

Zeki GÜNAYDIN
Mehmet GÜL
Deniz DEMİRCİ
Mehmet ERGELEN
Emre AKKAYA
Gökhan ÇİÇEK
Ayça TÜRER
Duygu DEMİRCİ
Ahmet NARİN
Hüseyin UYAREL
Erkan AYHAN
Pages
276–282
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Of these, 273 patients (11%) were found to have CKD (glomerular filtration rate

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We investigated the effect of chronic kidney disease (CKD) on in-hospital results in patients undergoing primary percutaneous angioplasty for ST-segment elevation myocardial infarction (STEMI).Study design: The study included 2,486 patients (2,070 men, 416 women) who were treated with primary angioplasty for STEMI.
📊
Key Findings & Data:Objectives: We investigated the effect of chronic kidney disease (CKD) on in-hospital results in patients undergoing primary percutaneous angioplasty for ST-segment elevation myocardial infarction (STEMI).Study design: The study included 2,486 patients (2,070 men, 416 women) who were treated with primary angioplasty for STEMI.
💡
Conclusion & Impact:Of these, 273 patients (11%) were found to have CKD (glomerular filtration rate
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We investigated the effect of chronic kidney disease (CKD) on in-hospital results in patients undergoing primary percutaneous angioplasty for ST-segment elevation myocardial infarction (STEMI).Study design: The study included 2,486 patients (2,070 men, 416 women) who were treated with primary angioplasty for STEMI. Of these, 273 patients (11%) were found to have CKD (glomerular filtration rate

Özet

Amaç: Bu çalışmada, ST yükselmeli miyokart enfarktüsü (STYME) ile kliniğimize başvuran ve primer anjiyoplasti uygulanan hastalarda kronik böbrek hastalığının (KBH) hastaneiçi klinik sonuçlar üzerine etkisi değerlendirildi.Çalışma planı: Çalışmaya STYME nedeniyle primer anjiyoplasti uygulanan 2486 hasta (2070 erkek, 416 kadın) alındı. Bu hastaların 273'ünde (%11) işlem öncesinde KBH saptandı (glomerül filtrasyon hızı

🔖

Cite This Article

GÜNAYDIN, Z., GÜL, M., DEMİRCİ, D., ERGELEN, M., AKKAYA, E., ÇİÇEK, G., TÜRER, A., DEMİRCİ, D., NARİN, A., UYAREL, H., AYHAN, E. (2022). The impact of chronic kidney disease on in-hospital clinical outcomes in patients undergoing primary percutaneous angioplasty for ST-segment elevation myocardial infarction. Türk Kardiyoloji Derneği Arşivi, Cilt: 39 - Sayı: 4, 276–282. https://ajindex.com/articles/633147

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Best PJ, Reddan DN, Berger PB, Szczech LA, McCullough PA, Califf RM. Cardiovascular disease and chronic kidney disease: insights and an update. Am Heart J 2004; 148:230-42
  2. Zhao L, Wang L, Zhang Y. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction 3. Walsh CR, O’Donnell CJ, Camargo CA Jr, Giugliano RP, Lloyd-Jones DM. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 2002;144:1003-11
  3. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002;137:563-70
  4. Marenzi G, Moltrasio M, Assanelli E, Lauri G, Marana I, Grazi M, et al. Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J 2007;153:755-62
  5. Bertomeu-Gonzalez V, Núñez J, Núñez E, Fácila L, Sanchis J, Bodí V, et al. Prognostic effect of renal dysfunction after ST-segment elevation myocardial infarction with and without heart failure. Int J Cardiol 2006;112:159-65
  6. Vasu S, Gruberg L, Brown DL. The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction. Catheter Cardiovasc Interv 2007;70:701-5
  7. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et.al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44:E1-E211
  8. Chan MY, Becker RC, Sim LL, Tan V, Lee CH, Low AF, et al. Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal function. Ann Acad Med Singapore 2010; 39:179-84
  9. Yamaguchi J, Kasanuki H, Ishii Y, Yagi M, Ogawa H, Fujii SY, et al. Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). Am J Cardiol 2004;93:1526-8
  10. Manjunath G, Tighiouart H, Ib